CTIS2023-508426-10-00招募中1 期
A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants with Relapsed/Refractory Multiple Myeloma
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase I randomized, open-label pharmacokinetic comparability study comparing pre- and post-change teclistamab in participants with relapsed/refractory multiple myelomaRelapsed/refractory multiple myelomaCancerISRCTN46766641Janssen-Cilag International NV100
已完成
不适用
A Phase 1, 2-part, Open Label Pharmacokinetic and Safety Study to Evaluate Dose Proportionality and Accumulation of Firdapse® (3,4-Diaminopyridine Phosphate) after Single and Multiple Oral Doses in Healthy Volunteersmuscle weakness10029317LEMSNL-OMON36156BioMarin Pharmaceutical Inc.26
终止
1 期
A Phase 1 study dosing with a Humira® (adalimumab) Enema in Patients with Active Ulcerative Colitis.lcerative colitisOral and Gastrointestinal - Inflammatory bowel diseaseInflammatory and Immune System - Other inflammatory or immune system disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonUlcerative colitisACTRN12620000932965Progenity Inc4
已完成
1 期
An Open-label Phase 1b Cross-over Pharmacokinetic Relative Bioavailability Study Comparing 2 Formulations of STG-001 in Healthy SubjectsACTRN12620000766910Stargazer Pharmaceuticals, Inc.10
进行中（未招募）
不适用
A Phase 1 Open-Label Study of the Pharmacokinetics of Tacrolimus Cream B 0.1% after Twice Daily Topical Administration in Adolescents (= 12 to = 17 Years of Age ) with Psoriasis - Tacrolimus Cream B 0.1% in AdolescentsEUCTR2006-002738-39-LVAstelleas Pharma US, Inc.20